Am J Transplant, Volume 22, Suppl 3 Archives - Page 115 of 190 - ATC Abstracts

2022 American Transplant Congress
The Impact of Having Potential Living Donors on Patients’ Access to Kidney Transplantation
E. J. Gordon¹, J. Lee¹, R. Kang¹, J. Caicedo²
¹Northwestern University Feinberg School of Medicine, Chicago, IL, ²Northwestern University, Chicago, IL
*Purpose: Racial/ethnic disparities persist in patients’ access to living donor kidney transplantation (LDKT). Little is known about the relationship between number of potential living donors…
2022 American Transplant Congress
Assessing the Impact of a Transplant Case Management Program on Clinical Outcomes: An Observational Cohort Study
A. Crossman
Healthcare Economics, Optum Health, Eden Prarie, MN
*Purpose: Case management is commonly used by payers to attempt to improve the care their members who have complex needs such as those who undergo…
2022 American Transplant Congress
Burden of Leukopenia/Neutropenia Among Adult Kidney Transplant Recipients: A Systematic Literature Review of Observational Studies
A. Raval¹, K. Kistler², Y. Tang¹, F. Vincenti³
¹Merck & Co., Inc., Kenilworth, NJ, ²Xcenda, Inc, Carrollton, TX, ³University of California, San Francisco, San Francisco, CA
*Purpose: Leukopenia/neutropenia (L/N) may affect key treatment decisions which could result in poor clinical and economic outcomes among kidney transplant recipients (KTRs). The burden of…
2022 American Transplant Congress
Outcomes in Hepatitis C (HCV) Viremic Grafts to HCV Negative Recipients in Heart Transplantation: A Multicenter Study of Differing Treatment Strategies
K. Ryland¹, B. Aqel², D. Steidley², P. Patel¹, S. Pungpapong³
¹Mayo Clinic, Jacksonville, FL, ²Mayo Clinic, Phoenix, AZ, ³Mayo Clinic College of Medicine, Jacksonville, FL
*Purpose: Using HCV viremic grafts for heart transplantation (HT) improves donor supply and shortens wait times. However, treatment strategies are variable post-transplant. This study aims…
2022 American Transplant Congress
Diagnostic Performance of Donor-Derived Cell-Free DNA Assay (AlloSure®) in Kidney Transplant Recipients with Graft Dysfunction: A Single Center Study
M. S. Naseer¹, H. Shokouh-Amiri², T. Creamer¹, R. McMillan², S. Tandukar¹, D. Aultman¹, G. B. Zibari¹, N. Singh¹
¹Transplant, John C. McDonald Regional Transplant Center - Willis Knighton Health System, Shreveport, LA, ²John C. McDonald Regional Transplant Center - Willis Knighton Health System, Shreveport, LA
*Purpose: Circulating donor-derived cell-free DNA (dd-cf-DNA) is a non-invasive biomarker of kidney allograft injury with a high negative predictive value for ruling out active rejection…
2022 American Transplant Congress
Comparison of CT Volumetry versus Nuclear Renography for Predicting Remaining Kidney Function After Uninephrectomy in Living Kidney Donors
S. Eum¹, H. Lee¹, E. Ko¹, H. Cho², H. Yoon³, S. Shin³, C. Yang¹, B. Chung¹
¹Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hospital, Seoul, Korea, Republic of, ²Department of Urology, Seoul St. Mary's Hospital, Seoul, Korea, Republic of, ³Division of Nephrology, Department of Internal Medicine, Incheon St. Mary's Hospital, Incheon, Korea, Republic of
*Purpose: Computed tomography (CT) and nuclear renography are used to determine kidney procurement strategy in living kidney donors (LKDs). The present study investigated which modality…
2022 American Transplant Congress
Outcomes of Living Donor Liver Transplant Using Low Graft Recipient Weight Ratio (GRWR ≤ 0.8)
V. Gunabushanam, S. Ganesh, A. Tevar, A. Ganoza, M. Molinari, C. Hughes, A. Humar
University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: Low Graft recipient ratio (≤ 0.8) in adult living donor liver transplantation is considered a major risk factor affecting patient and graft survival. The…
2022 American Transplant Congress
Clinically Available Immunosuppressive Agents Prolong Pig-to-Primate Kidney Xenograft Survival
I. J. Anwar¹, Q. Gao¹, I. DeLaura¹, J. Yoon¹, R. Baldi¹, M. Youd², K. Stiede², K. Hall², S. Knechtle¹, J. Kwun¹
¹Surgery, Duke Transplant Center, Durham, NC, ²eGenesis Inc, Cambridge, MA
*Purpose: Most immunosuppressive regimens used in Pig-To-Primate Xenotransplantation contain anti-CD154 agents, compounds that are currently not FDA-approved. The aim of this study was to assess…
2022 American Transplant Congress
Kidney Transplant Recipients with Diabetic Mellitus Demand Larger Doses of Mycophenolate Mofetil
D. Takamoto, H. Sasaki, S. Harada, Y. Takada, H. Harada, T. Tsujimoto
Kidney transplant surgery and Urology, Sapporo City General Hospital, Sapporo, Japan
*Purpose: To monitor blood concentration of immunosuppressants, therapeutic drug monitoring (TDM) is required at any point after kidney transplantation (KT) to prevent kidney graft from…
2022 American Transplant Congress
Results of a Pilot Adherence Activity for Pharmacy Learners on a Solid Organ Transplant Service
J. Zumbrunnen
Pharmacy, Emory University Hospital, Atlanta, GA
*Purpose: The purpose was to determine if the ability of pharmacy learners to educate patients and help overcome barriers to medication adherence is improved after…